Argenx Se (ARGX) Net Income Growth (3y) (2019 - 2026)
Argenx Se (ARGX) Net Income Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | 79.26% |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 37.34 Bn | 34.33 Bn | 959.66 Mn | 47.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.26% |
| Mar 31, 2026 | 86.98% |
| Dec 31, 2025 | 129.89% |
| Sep 30, 2025 | 20.10% |
| Jun 30, 2025 | 32.84% |
| Mar 31, 2025 | 7.01% |
| Dec 31, 2024 | -30.70% |
| Sep 30, 2024 | 33.90% |
| Jun 30, 2024 | -28.87% |
| Mar 31, 2024 | -74.60% |
| Dec 31, 2023 | 32.01% |
| Sep 30, 2023 | 25.15% |
| Jun 30, 2023 | 29.86% |
| Mar 31, 2023 | -7.58% |
| Dec 31, 2022 | 29.37% |
| Sep 30, 2022 | 23.52% |
| Jun 30, 2022 | -121.25% |
| Mar 31, 2022 | 200.21% |
| Dec 31, 2021 | 110.64% |
| Sep 30, 2021 | -112.70% |